Inhaled Nitric Oxide Market 2022 Emerging Trends, CAGR Status, Growth, Analysis and Forecast to 2027

Nitric oxide is primarily used to help the body efficiently absorb oxygen. It achieves this by effectively dilating blood vessels and relaxing muscle tension. Ventilators and nitric oxide are used in combination with each other. On inhalation, nitric oxide becomes a selective pulmonary vasodilator that does not hamper systemic vascular tone. Inhaled nitric oxide therapy is applied as a treatment method for persistent pulmonary hypertension (PPHN) by effectively improving oxygenation in infants. Due to its selective pulmonary vasodilator properties, nitric oxide also helps in preventing hypoxemic respiratory failures caused by PPHN. Owing to these reasons, inhaled nitric oxide therapy is used to clinically treat PPHN in term and late preterm neonates without consensus.

Looking For a Sample Copy of This Report? Request the Same Here: https://www.fairfieldmarketresearch.com/report/inhaled-nitric-oxide-market/request-sample

As persistent pulmonary hypertension and neonatal hypoxic respiratory failure become increasingly common among infants and new-borns, the market for inhaled nitric oxide is experiencing sturdy growth. Similarly, an increasing number of patients developing acuta distress syndrome and chronic obstructive pulmonary disease is also facilitating growth across the global market.

COVID-19 Projected to Become a Key Factor Contributing to Market Growth for Inhaled Nitric Oxide

As COVID-19 is primarily related to respiratory issues, nitric oxide is being tested as an experimental treatment for the virus. It is also being applied to protect frontline healthcare professionals for contracting a potentially fatal disease. Moreover, inhaled nitric oxide is used for curing ARDS, pulmonary hypertension, and other respiratory diseases, while numerous clinical trials are being carried out to understand the effects of inhaled nitric oxide on the coronavirus. It has been found that inhaled gas can have therapeutic benefits in COVID-19 patients by preventing further damage to the vessels inside the lungs.

North America Dominates the Regional Landscape for Global Inhaled Nitric Oxide Market

The outbreak of COVID-19 has elevated the risk of respiratory conditions and is estimated to accelerate growth of the global inhaled nitric oxide market in the coming years. North America is projected to be the fastest growing market across the regional landscape. Chronic diseases such as asthma, obesity, heart diseases, lung disorders, and respiratory disorders are increasingly affecting the people of this region. Improved healthcare infrastructure and an accelerated pace of manufacturing across production facilities in the region is spurring market growth. Furthermore, increasing investments in research and development activities is expected to augur application of inhaled nitric oxide in key areas across the region. Furthermore, In March, the U.S. FDA gave multiple pharmaceutical companies emergency clearance to allow the use of nitric oxide devices to treat patients affected with COVID-19.

Asia-Pacific is also projected to undergo rapid growth and become the fastest growing region due to the highest number of live births per 1000 people and increasing incidence of respiratory disorders in new-borns.

Do You Have Any Query or Specific Requirement? Request Customization of Report: https://www.fairfieldmarketresearch.com/report/inhaled-nitric-oxide-market/request-customization

Pharmaceutical Companies Reported to Experiment with Nitric Oxide Devices to Treat Patients Affected with COVID-19

Key players such as Mallinckrodt have invested in research for the use of inhaled nitric oxide to treat and manage symptoms in COVID-19 patients. Some more important names in the market for inhaled nitric oxide market include Bellerophon Therapeutics, Inc. Air Liquide S.A., Boc Healthcare, Vero Biotech Llc, Beyond Air, Inc., Halma Plc, Linde Plc (Praxair, Inc.), Nu-Med Plus, Mallinckrodt Plc, and Novoteris, Llc.

Browse Trending Reports by Fairfield Market Research-

Mouth Ulcers Treatment Market- https://www.globenewswire.com/en/news-release/2022/05/24/2449588/0/en/Mouth-Ulcers-Treatment-Market-Reaches-US-2-047-9-Mn-by-2026-From-in-US-1-690-6-Mn-2021-at-a-Healthy-3-9-CAGR-Fairfield-Market-Research.html

Vehicle Battery Market-https://www.globenewswire.com/en/news-release/2022/05/16/2444120/0/en/Vehicle-Battery-Market-Size-to-Exceed-US-43-3-Bn-by-2030-End-China-to-Remain-Global-Hub-Fairfield-Market-Research.html

Lithium Mining Market-https://www.globenewswire.com/en/news-release/2022/05/12/2442146/0/en/Global-Lithium-Mining-Market-Stood-at-US-829-73-Mn-in-2019-and-is-Expected-to-Reach-US-1-630-30-Mn-by-2025-Registering-a-CAGR-of-26-3-Fairfield-Market-Research.html

Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA +1 (844) 3829746 (Toll-free)
Email: sales@fairfieldmarketresearch.com
Web: https://www.fairfieldmarketresearch.com/
Follow Us: https://bit.ly/3voYIm9

About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

This release was published on openPR.